Page last updated: 2024-09-20

aristolochic acid i

Description

aristolochic acid I: phospholipase A inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
AristolochiagenusA plant genus of the family ARISTOLOCHIACEAE. Species of this genus have been used in traditional medicine but they contain aristolochic acid which is associated with nephropathy. These are sometimes called 'snakeroot' but that name is also used with a number of other plants such as POLYGALA; SANICULA; ASARUM; ARISTOLOCHIA; AGERATINA; and others.[MeSH]AristolochiaceaeA plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida. They are mostly tropical woody vines and a few temperate-zone species. The flowers are 3-parted; some species lack petals while others are large and foul smelling.[MeSH]

Cross-References

ID SourceID
PubMed CID2236
CHEMBL ID93353
CHEBI ID2825
SCHEMBL ID166284
MeSH IDM0040292

Synonyms (139)

Synonym
MLS002695974
chebi:2825 ,
CHEMBL93353 ,
8-methoxy-3,4-methylendioxxy-10-nitro-1-phenanthrencarbonsaeure
phenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-
nsc 11926
brn 0345159
birthwort
einecs 206-238-3
8-methoxy-6-nitrophenanthol (3,4-d) 1,3-dioxole-5-carboxylic acid
aristolochic acid-i
8-methoxy-3,4-methylenedioxy-10-nitrophenanthrene-1-carboxylic acid
8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid
ccris 1544
aristolochiazaeure
aristolochine
nsc 50413
3,4-methylenedioxy-8-methoxy-10-nitro-1-phenanthrenecarboxylic acid
c17h11no7
nsc-50413
KBIO1_001488
DIVK1C_006544
NCIMECH_000812
SPECTRUM4_001952
SPECTRUM_001156
IDI1_033910
tardolyt
tr 1736
nsc-11926
mls002702976 ,
nsc11926 ,
aristolochin
phenanthro[3,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-
BIO2_000640
BIO1_000418
BIO1_001396
BIO2_000160
BIO1_000907
tnp00273
NCGC00017334-01
BSPBIO_002848
BSPBIO_001440
8-methoxy-6-nitro-naphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid
phenanthro[3,4-d]-1,3-dioxole-5-carbocylic acid, 8-methoxy-6-nitro-
aristolochic acid a
NSC50413 ,
313-67-7
C08469
aristolochic acid
aristolochic acid i
aristolochic acid i, powder
NCGC00095981-03
NCGC00095981-01
NCGC00095981-02
KBIOSS_001636
KBIO3_000320
KBIO2_001636
KBIOSS_000160
KBIO3_000319
KBIOGR_000160
KBIO2_005296
KBIO3_002068
NCI60_000460
KBIOGR_002387
KBIO2_002728
KBIO2_006772
KBIO2_004204
KBIO2_000160
SPECPLUS_000448
SPECTRUM2_000822
SPECTRUM3_001114
SPBIO_000743
SPECTRUM1502233
SPECTRUM5_000729
NCGC00095981-05
NCGC00095981-04
8-methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylic acid
HMS1989H22
smr001562128
HMS1791H22
HMS1361H22
2-naphthyl pyrovalerone-d8 hydrochloride
bdbm50306855
8-methoxy-6-nitro-phenanthro[3,4-d][1,3]dioxole-5-carboxylic acid
8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid
S9193
CCG-36162
CCG-35796
NCGC00017334-02
NCGC00017334-04
NCGC00017334-05
NCGC00017334-03
NCGC00017334-06
NCGC00017334-07
aristolochic acid 1
94218wfp5t ,
unii-94218wfp5t
FT-0602867
AKOS015896751
aristolochic acid, plants containing [iarc]
aristolochic acid [who-dd]
aristolochic acid [iarc]
aristolochia a
aristolochic acid [mi]
tr-1736
SCHEMBL166284
AC-34489
Q-100394
aristolochic-acid-a
8-methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylic acid #
phenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-
BBFQZRXNYIEMAW-UHFFFAOYSA-N
HMS3402H22
DTXSID0040969 ,
mfcd00004996
sr-05000002369
SR-05000002369-2
SR-05000002369-3
aristolochia, european pharmacopoeia (ep) reference standard
aristolochic acid i, european pharmacopoeia (ep) reference standard
aris-tolochic acid
1246815-48-4
BS-16911
aristolochic acid a,(s)
Q21099362
goq ,
8-methoxy-6-nitro-naphtho[1,2-e][1,3]benzodioxole-5-carboxylic acid
CS-0009050
aristolochic acid i;tr 1736
mixture of aristolochic acid a and b
HY-N0510
XA167153
aristolochicacida
aristolochia
gtpl12438
aristolochic acid, plants containing (iarc)
8-methoxy-6-nitrophenanthro(3,4-d)(1,3)dioxole-5-carboxylic acid
dtxcid8020969
aristolochic acid (iarc)

Research Excerpts

Overview

ExcerptReference
"Aristolochic acid I (AAI) is a well established nephrotoxin and human carcinogen. "( Chen, C; Chen, SZ; Chen, XF; Dong, YP; Fan, ZC; Feng, F; Gu, YQ; He, HS; Jiang, LX; Sun, ZR; Wang, HY; Wen, W; Zhang, Y, 2023)
"Aristolochic Acid I (AAI) is an environmental and foodborne toxin found in the Aristolochia and Asarum species of plants that are widespread all over the world. "( Chen, M; Ke, S; Li, J; Liu, X; Tian, J; Yu, BY; Yu, H, 2023)
"Aristolochic acid I (AAI) is a well-known genotoxic kidney carcinogen. "( Abdullah, R; Louisse, J; Punt, A; Rietjens, IMCM; Spenkelink, B; Wesseling, S, 2020)
"Aristolochic acid I (AAI) is a potent nephrotoxic and carcinogenic compound produced by plants of the Aristolochiaceae family and thoroughly investigated as a main culprit in the etiology of Balkan endemic nephropathy (BEN). "( Drăghia, LP; Lukinich-Gruia, AT; Oprean, C; Păunescu, V; Pavlović, NM; Tatu, CA, 2021)
"Aristolochic acid I (AAI) is a phytocompound that is linked to the progressive renal disease and development of human urothelial carcinoma. "( Huang, YT; Liu, BH; Lu, CC; Wu, TS; Yu, FY, 2018)
"Aristolochic acid I is a nephrotoxic compound widely existing in many kinds of traditional Chinese medicines, especially in Aristolochiaceae medicinal plants. "( Chang, C; Du, W; Fu, Q; Ge, Y; Guo, PQ; Liu, RL; Luo, ZM; Shu, H; Xu, XY, 2018)
"Aristolochic acid I (AAI) is a potent carcinogen and was found to be toxic in animal and clinical studies."( Kwak, DH; Lee, HS; Lee, S; Moon, JS; Park, JH, 2014)
"Aristolochic acid I (AAI) is a plant alkaloid causing aristolochic acid nephropathy, Balkan endemic nephropathy and their associated urothelial malignancies. "( Arlt, VM; Bárta, F; Hodek, P; Levová, K; Martínek, V; Schmeiser, HH; Stiborová, M, 2015)
"Aristolochic acid I (AAI) is a natural plant alkaloid causing aristolochic acid nephropathy, Balkan endemic nephropathy and their associated urothelial malignancies. "( Arlt, VM; Bárta, F; Dračínská, H; Frei, E; Hudecová, A; Kopka, K; Levová, K; Moserová, M; Schmeiser, HH; Stiborová, M, 2016)
"Aristolochic acid I (AAI) is a plant drug found in Aristolochia species that causes aristolochic acid nephropathy, Balkan endemic nephropathy and their associated urothelial malignancies. "( Arlt, VM; Bárta, F; Frei, E; Martínek, V; Milichovský, J; Schmeiser, HH; Stiborová, M, 2016)
"Aristolochic acid I (AA-I) is a strong nephrotoxin, carcinogen, and mutagen found in plants such as the Aristolochia species. "( Cai, SQ; Jia, Y; Li, XM; Li, XW; Shang, MY; Shoyama, Y; Tan, HR; Wang, D; Wang, X; Xu, F; Yang, L; Yang, XX, 2016)
"Aristolochic acid I (AAI) is a phytotoxin that has been found in various herbal remedies and linked to the development of human carcinogenesis. "( Lin, TH; Liu, BH; Liu, MC; Lu, CC; Wu, TS; Yu, FY, 2011)
"Aristolochic acid I (AAI) is a primary nephrotoxin and carcinogen that is found in some Chinese herbal medicines, and AAI is responsible for the progression of aristolochic acid nephropathy. "( Cheng, J; Dou, Y; Du, Y; Li, L; Lou, Y; Tan, Y; Yang, H; Zheng, X; Zhu, D, 2011)
"Aristolochic acid I (AA-I), which is a known nephrotoxin, is found in a commonly used Chinese medicine, Xixin, that originates from nine Asarum species (Aristolochiaceae) found in China. "( Cai, SQ; Chiang, ST; Hsai, JL; Hsiao, SS; Jong, TT; Lee, MR; Wu, TS, 2003)

Effects

ExcerptReference
"Aristolochic acid I (AAI) has been widely found in herbal remedies and linked to the development of nephropathy and urothelial carcinoma in humans. "( Chen, TW; Liu, BH; Wu, TS; Yu, FY, 2011)
"Aristolochic acid itself has no influence on the number of rosettes but compensates the diminuation caused by prednisolone."( Müller, HJ; Siering, H, 1981)

Actions

ExcerptReference
"Aristolochic acid is the cause of aristolochic acid nephropathy (AAN) and Balkan endemic nephropathy (BEN) and their associated urothelial malignancies. "( Arlt, VM; Bárta, F; Frei, E; Levová, K; Schmeiser, HH; Stiborová, M, 2014)

Roles (5)

RoleDescription
nephrotoxinA poison that interferes with the function of the kidneys.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
toxinPoisonous substance produced by a biological organism such as a microbe, animal or plant.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
cyclic acetalAn acetal in the molecule of which the acetal carbon and one or both oxygen atoms thereon are members of a ring.
organic heterotetracyclic compound
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
aristolochic acidsOrganic heterotetracyclic compounds which are a group of nitro phenanthrene organic acids, naturally found in many kinds of plants, such as Aristolochia and Asarum, and widely cultivated in Asia.They are identified as a class 1 human carcinogen by the International Agency for Research on Cancer owing to their carcinogenicity and nephrotoxicity and can pose a significant hazard to food safety and human health.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (35)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency22.33420.140911.194039.8107AID2451
glp-1 receptor, partialHomo sapiens (human)Potency28.18380.01846.806014.1254AID624417
GLS proteinHomo sapiens (human)Potency12.58930.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency19.96550.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency14.83250.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency34.81060.011212.4002100.0000AID1030
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency11.58210.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency31.62283.548119.542744.6684AID743266
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency14.12540.425612.059128.1838AID504891
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency14.12540.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency14.12540.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency14.12540.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency14.72130.00798.23321,122.0200AID2546
gemininHomo sapiens (human)Potency4.10950.004611.374133.4983AID624296
survival motor neuron protein isoform dHomo sapiens (human)Potency10.00000.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency6.02520.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency10.00000.020010.786931.6228AID912
DNA dC->dU-editing enzyme APOBEC-3F isoform aHomo sapiens (human)Potency7.94330.025911.239831.6228AID602313
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency6.68771.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cyclin-dependent kinase 2Homo sapiens (human)IC50 (µMol)20.00000.00041.044410.0000AID457604
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (31)

Processvia Protein(s)Taxonomy
G1/S transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICyclin-dependent kinase 2Homo sapiens (human)
DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
DNA repairCyclin-dependent kinase 2Homo sapiens (human)
chromatin remodelingCyclin-dependent kinase 2Homo sapiens (human)
DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
potassium ion transportCyclin-dependent kinase 2Homo sapiens (human)
centriole replicationCyclin-dependent kinase 2Homo sapiens (human)
Ras protein signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of cell population proliferationCyclin-dependent kinase 2Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of heterochromatin formationCyclin-dependent kinase 2Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated DNA replication initiationCyclin-dependent kinase 2Homo sapiens (human)
telomere maintenance in response to DNA damageCyclin-dependent kinase 2Homo sapiens (human)
post-translational protein modificationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
centrosome duplicationCyclin-dependent kinase 2Homo sapiens (human)
cell divisionCyclin-dependent kinase 2Homo sapiens (human)
meiotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
cellular response to nitric oxideCyclin-dependent kinase 2Homo sapiens (human)
cellular senescenceCyclin-dependent kinase 2Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processCyclin-dependent kinase 2Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 2Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
histone kinase activityCyclin-dependent kinase 2Homo sapiens (human)
magnesium ion bindingCyclin-dependent kinase 2Homo sapiens (human)
protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein bindingCyclin-dependent kinase 2Homo sapiens (human)
ATP bindingCyclin-dependent kinase 2Homo sapiens (human)
protein domain specific bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
chromosome, telomeric regionCyclin-dependent kinase 2Homo sapiens (human)
condensed chromosomeCyclin-dependent kinase 2Homo sapiens (human)
X chromosomeCyclin-dependent kinase 2Homo sapiens (human)
Y chromosomeCyclin-dependent kinase 2Homo sapiens (human)
male germ cell nucleusCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
nuclear envelopeCyclin-dependent kinase 2Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
endosomeCyclin-dependent kinase 2Homo sapiens (human)
centrosomeCyclin-dependent kinase 2Homo sapiens (human)
cytosolCyclin-dependent kinase 2Homo sapiens (human)
Cajal bodyCyclin-dependent kinase 2Homo sapiens (human)
cyclin A1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin A2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 2Homo sapiens (human)
transcription regulator complexCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID1745849Viability Counterscreen for CMV-Luciferase Assay of Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1745847CMV-Luciferase Counterscreen for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745846Firefly Luciferase Counterscreen for Inhibitors of ATXN expression
AID1745848Confirmatory qHTS for Inhibitors of ATXN expression
AID1745850Viability Counterscreen for Confirmatory qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID344455Antispasmodic activity in guinea pig ileum assessed as inhibition of acetylcholine-induced smooth muscle contraction2008Journal of natural products, Jul, Volume: 71, Issue:7
Chemical constituents of Aristolochia constricta: antispasmodic effects of its constituents in guinea-pig ileum and isolation of a diterpeno-lignan hybrid.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID457612Inhibition of CDK2 at 50 uM2010Bioorganic & medicinal chemistry letters, Feb-15, Volume: 20, Issue:4
Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.
AID247402Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program2005Journal of medicinal chemistry, Mar-10, Volume: 48, Issue:5
CHMIS-C: a comprehensive herbal medicine information system for cancer.
AID578749Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A novel alkaloid, aristopyridinone A and anti-inflammatory phenanthrenes isolated from Aristolochia manshuriensis.
AID578748Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A novel alkaloid, aristopyridinone A and anti-inflammatory phenanthrenes isolated from Aristolochia manshuriensis.
AID678071Mutagenicity in Salmonella typhimurium TA1002012Journal of natural products, Jul-27, Volume: 75, Issue:7
Aristoxazole analogues. Conversion of 8-nitro-1-naphthoic acid to 2-methylnaphtho[1,2-d]oxazole-9-carboxylic acid: comments on the chemical mechanism of formation of DNA adducts by the aristolochic acids.
AID398939Toxicity in Sprague-Dawley rat at 40 mg/kg
AID344454Antispasmodic activity in guinea pig ileum assessed as inhibition of electrically-induced smooth muscle contraction2008Journal of natural products, Jul, Volume: 71, Issue:7
Chemical constituents of Aristolochia constricta: antispasmodic effects of its constituents in guinea-pig ileum and isolation of a diterpeno-lignan hybrid.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID457604Inhibition of CDK22010Bioorganic & medicinal chemistry letters, Feb-15, Volume: 20, Issue:4
Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.
AID398946Antifertility effect in Sprague-Dawley rat assessed as number of pregnant animals at 10 mg/kg administered postcoitally for 1 to 10 days
AID398940Toxicity in golden syrian hamster at 25 mg/kg
AID398941Antifertility effect in Sprague-Dawley rat assessed as number of pregnant animals at 40 mg/kg, po administered postcoitally for 1 to 10 days
AID1506511Cytotoxicity in HEK293 cells assessed as reduction in cell survival incubated for 48 hrs by MTT assay2017MedChemComm, Feb-01, Volume: 8, Issue:2
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
AID227700Anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
AID678072Drug conversion assessed as formation of oxazole derivatives in presence of Zn/HOAc2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Aristoxazole analogues. Conversion of 8-nitro-1-naphthoic acid to 2-methylnaphtho[1,2-d]oxazole-9-carboxylic acid: comments on the chemical mechanism of formation of DNA adducts by the aristolochic acids.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,064)

TimeframeStudies, This Drug (%)All Drugs %
pre-199057 (5.36)18.7374
1990's78 (7.33)18.2507
2000's327 (30.73)29.6817
2010's448 (42.11)24.3611
2020's154 (14.47)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.18%)5.53%
Reviews71 (6.53%)6.00%
Case Studies31 (2.85%)4.05%
Observational2 (0.18%)0.25%
Other982 (90.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (91)

ArticleYear
Investigation of the applicability of the zebrafish model for the evaluation of aristolochic acid-related nephrotoxicity.
Phytomedicine : international journal of phytotherapy and phytopharmacology, Volume: 121
2023
MiR-766-3p and miR-671-5p attenuate aristolochic acid-induced hepatotoxicity by directly targeting the key bioactivating enzyme NQO1.
Ecotoxicology and environmental safety, Volume: 261
2023
Study on the difference and correlation between the contents and toxicity of aristolochic acid analogues in Aristolochia plants.
Journal of ethnopharmacology, Oct-28, Volume: 315
2023
Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.
Phytomedicine : international journal of phytotherapy and phytopharmacology, Volume: 114
2023
The Presence of Testis Determines Aristolochic Acid-Induced Nephrotoxicity in Mice.
Toxins, 02-01, Volume: 15, Issue: 2
2023
Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice.
Journal of ethnopharmacology, May-10, Volume: 307
2023
[Risk assessment, safe medication and scientific supervision of traditional Chinese medicine containing aristolochic acids--toxicity is different among aristolochic acids, and detection and control of aristolochic acid Ⅰ/Ⅱ is critical].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 47, Issue: 14
2022
Protective Effects of Mitochondrial Uncoupling Protein 2 against Aristolochic Acid I-Induced Toxicity in HK-2 Cells.
International journal of molecular sciences, Mar-27, Volume: 23, Issue: 7
2022
Schisandra chinensis Oil Attenuates Aristolochic Acid I-Induced Nephrotoxicity in vivo and in vitro.
Chinese journal of integrative medicine, Volume: 28, Issue: 7
2022
Differential comparison of genotoxic effects of aristolochic acid I and II in human cells by the mass spectroscopic quantification of γ-H2AX.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 81
2022
Study on the potential nephrotoxicity and mutagenicity of aristolochic acid IVa and its mechanism.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Volume: 142
2021
Berberine-Based Heterogeneous Linear Supramolecules Neutralized the Acute Nephrotoxicity of Aristolochic Acid by the Self-Assembly Strategy.
ACS applied materials & interfaces, Jul-21, Volume: 13, Issue: 28
2021
Evaluation of the nephrotoxicity and safety of low-dose aristolochic acid, extending to the use of Xixin (Asurum), by determination of methylglyoxal and d-lactate.
Journal of ethnopharmacology, May-23, Volume: 272
2021
Benchmark dose analysis of multiple genotoxicity endpoints in gpt delta mice exposed to aristolochic acid I.
Mutagenesis, 04-28, Volume: 36, Issue: 1
2021
Kidney-based in vivo model for drug-induced nephrotoxicity testing.
Scientific reports, 08-14, Volume: 10, Issue: 1
2020
Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches.
International journal of molecular sciences, Feb-10, Volume: 21, Issue: 3
2020
Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice.
The Korean journal of internal medicine, Volume: 35, Issue: 2
2020
The Disturbance of Hepatic and Serous Lipids in Aristolochic Acid Ι Induced Rats for Hepatotoxicity Using Lipidomics Approach.
Molecules (Basel, Switzerland), Oct-17, Volume: 24, Issue: 20
2019
Untargeted LC-MS-based metabonomics revealed that aristolochic acid I induces testicular toxicity by inhibiting amino acids metabolism, glucose metabolism, β-oxidation of fatty acids and the TCA cycle in male mice.
Toxicology and applied pharmacology, 06-15, Volume: 373
2019
Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
Toxicology, 05-15, Volume: 420
2019
Environmental and Genetic Factors Influencing Kidney Toxicity.
Seminars in nephrology, Volume: 39, Issue: 2
2019
Acute Toxicity and Sub-lethal Effects of the Essential Oil of Aristolochia trilobata and Its Major Constituents on Nasutitermes corniger (Termitidae: Nasutitermitinae).
Neotropical entomology, Volume: 48, Issue: 3
2019
Recognition of the toxicity of aristolochic acid.
Journal of clinical pharmacy and therapeutics, Volume: 44, Issue: 2
2019
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
MedChemComm, Feb-01, Volume: 8, Issue: 2
2017
[Current research situation of nephrotoxicity of Chinese herbal medicine].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 43, Issue: 3
2018
[Study and opinion on toxicity of aristolochic acid].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 42, Issue: 21
2017
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.
JCI insight, 11-16, Volume: 2, Issue: 22
2017
Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats.
Toxicological sciences : an official journal of the Society of Toxicology, 03-01, Volume: 156, Issue: 1
2017
Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity.
PloS one, Volume: 11, Issue: 10
2016
Expression of Renal Aquaporins in Aristolochic Acid I and Aristolactam I-Induced Nephrotoxicity.
Nephron, Volume: 133, Issue: 3
2016
Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 92
2016
Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, Volume: 21, Issue: 3
2016
[Application of ultra high performance liquid chromatography-mass spectrometry to metabolomics study of drug-induced hepatotoxicity].
Se pu = Chinese journal of chromatography, Volume: 33, Issue: 7
2015
Aristolochic Acid I Causes Testis Toxicity by Inhibiting Akt and ERK1/2 Phosphorylation.
Chemical research in toxicology, Jan-19, Volume: 29, Issue: 1
2016
New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 87
2016
Evaluation of nephrotoxic effects of aristolochic acid on zebrafish (Danio rerio) larvae.
Human & experimental toxicology, Volume: 35, Issue: 9
2016
In vitro genotoxicity tests point to an unexpected and harmful effect of a Magnolia and Aristolochia association.
Journal of ethnopharmacology, Nov-04, Volume: 174
2015
Vitamin C attenuates the toxic effect of aristolochic acid on renal tubular cells via decreasing oxidative stress‑mediated cell death pathways.
Molecular medicine reports, Volume: 12, Issue: 4
2015
Safety concerns of herbal products and traditional Chinese herbal medicines: dehydropyrrolizidine alkaloids and aristolochic acid.
Journal of applied toxicology : JAT, Volume: 35, Issue: 12
2015
Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.
Bioanalysis, Volume: 7, Issue: 6
2015
In vitro effects of Panax ginseng in aristolochic acid-mediated renal tubulotoxicity: apoptosis versus regeneration.
Planta medica, Volume: 81, Issue: 5
2015
Human bone morphogenetic protein-7 does not counteract aristolochic acid-induced renal toxicity.
Journal of applied toxicology : JAT, Volume: 35, Issue: 12
2015
Toxicity of aristolochic acids isolated from Aristolochia indica Linn (Aristolochiaceae) against the malarial vector Anopheles stephensi Liston (Diptera: Culicidae).
Experimental parasitology, Volume: 153
2015
Aristolochic Acid I induces ovarian toxicity by inhibition of akt phosphorylation.
Chemical research in toxicology, Dec-15, Volume: 27, Issue: 12
2014
[Advance in studies on toxicity of aristolochic acid and analysis on risk factors].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 39, Issue: 12
2014
Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity.
Life sciences, Sep-26, Volume: 114, Issue: 1
2014
Acute and subacute toxicity of the extract of Aristolochiae fructus and honey-fried Aristolochiae fructus in rodents.
Biological & pharmaceutical bulletin, Volume: 37, Issue: 3
2014
Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs.
Food chemistry, Mar-15, Volume: 147
2014
Evaluation of the cytotoxicity and genotoxicity of aristolochic acid I - a component of Aristolochiaceae plant extracts used in homeopathy.
Environmental toxicology and pharmacology, Volume: 35, Issue: 2
2013
Antitubercular activity and the subacute toxicity of (-)-Licarin A in BALB/c mice: a neolignan isolated from Aristolochia taliscana.
Archives of medical research, Volume: 44, Issue: 2
2013
The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats.
BMC complementary and alternative medicine, Oct-03, Volume: 12
2012
Possible role of mtDNA depletion and respiratory chain defects in aristolochic acid I-induced acute nephrotoxicity.
Toxicology and applied pharmacology, Jan-15, Volume: 266, Issue: 2
2013
Developmental nephrotoxicity of aristolochic acid in a zebrafish model.
Toxicology and applied pharmacology, May-15, Volume: 261, Issue: 1
2012
Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.
Toxins, Volume: 2, Issue: 8
2010
Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
Molecular pharmaceutics, Dec-05, Volume: 8, Issue: 6
2011
Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
Toxicological sciences : an official journal of the Society of Toxicology, Volume: 122, Issue: 2
2011
Evaluation of microwave-assisted extraction for aristolochic acid from Aristolochiae Fructus by chromatographic analysis coupled with nephrotoxicity studies.
Biomedical chromatography : BMC, Volume: 26, Issue: 2
2012
Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.
American journal of physiology. Renal physiology, Volume: 300, Issue: 6
2011
Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
The American journal of pathology, Volume: 178, Issue: 3
2011
[Comparative study on metabonomics and on liver and kidney toxicity of Aristolochia fangchi and Stephania tetrandra].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 35, Issue: 21
2010
Comparative nephrotoxicity of aristolochic acid and tetrandrine in vitro and in vivo.
International journal of toxicology, Volume: 30, Issue: 1
2011
Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
International journal of cancer, Sep-01, Volume: 127, Issue: 5
2010
Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment.
Toxicology and applied pharmacology, Mar-01, Volume: 243, Issue: 2
2010
[Nephrotoxicity study of Aristolochia fangchi in rats by metabonomics].
Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, Volume: 7, Issue: 8
2009
[Effects of cytochrome P450 isozymes on aristolochic acid renal cytotoxicity].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 33, Issue: 17
2008
Comparative study on the aristolochic acid I content of Herba Asarifor safe use.
Phytomedicine : international journal of phytotherapy and phytopharmacology, Volume: 15, Issue: 9
2008
Comparative 28-day repeated oral toxicity of Longdan Xieganwan, Akebia trifoliate (Thunb.) koidz., Akebia quinata (Thunb.) Decne. and Caulis aristolochiae manshuriensis in mice.
Journal of ethnopharmacology, Sep-02, Volume: 119, Issue: 1
2008
Species-specific toxicity of aristolochic acid (AA) in vitro.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 22, Issue: 5
2008
Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity.
Kidney international, Volume: 73, Issue: 11
2008
Short-term toxicity of aristolochic acid, aristolochic acid-I and aristolochic acid-II in rats.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 46, Issue: 3
2008
[Nephrotoxicity of Radix Aristolochice and it's substitution material Radix Inulae in rats].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 32, Issue: 19
2007
[Nephrotoxicity of Aristolochia manshriensis and Longdan Xiegan decoction].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 32, Issue: 7
2007
Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.
Toxicon : official journal of the International Society on Toxinology, Volume: 50, Issue: 2
2007
Genotoxic effect and nitrative DNA damage in HepG2 cells exposed to aristolochic acid.
Mutation research, Jun-15, Volume: 630, Issue: 1-2
2007
Selective toxicity of aristolochic acids I and II.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 35, Issue: 7
2007
In vitro cytotoxicity assay with selected chemicals using human cells to predict target-organ toxicity of liver and kidney.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 21, Issue: 4
2007
Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat.
FEBS letters, Feb-20, Volume: 581, Issue: 4
2007
[The nephrotoxicity in rats caused by Longdan Xiegan decoction].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 31, Issue: 10
2006
Metabonomic study of aristolochic acid-induced nephrotoxicity in rats.
Journal of proteome research, Volume: 5, Issue: 4
2006
Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line.
Nephron. Experimental nephrology, Volume: 103, Issue: 3
2006
NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 44, Issue: 7
2006
[Nephrotoxicity of Aristolochia manshuriensis and aristolochic acids in mice].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 30, Issue: 13
2005
Molecular mechanisms of toxicity of important food-borne phytotoxins.
Molecular nutrition & food research, Volume: 49, Issue: 2
2005
Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 42, Issue: 12
2004
Studies on the toxicity of Aristolochia manshuriensis (Guanmuton).
Toxicology, May-20, Volume: 198, Issue: 1-3
2004
Acute nephrotoxicity of aristolochic acids in mice.
The Journal of pharmacy and pharmacology, Volume: 56, Issue: 2
2004
The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids.
Clinical and experimental nephrology, Volume: 7, Issue: 3
2003
Role of phospholipase A2 activation and calcium in CYP2E1-dependent toxicity in HepG2 cells.
The Journal of biological chemistry, Sep-05, Volume: 278, Issue: 36
2003
Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.
Archives of toxicology, Volume: 77, Issue: 4
2003
Toxicity of the Chinese herb mu tong (Aristolochia manshuriensis). What history tells us.
Adverse drug reactions and toxicological reviews, Volume: 21, Issue: 4
2002
Acute toxicity of aristolochic acid in rodents.
Archives of toxicology, Volume: 59, Issue: 5
1987
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (6)

ArticleYear
Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice.
Journal of ethnopharmacology, May-10, Volume: 307
2023
Mechanism of chronic aristolochic acid nephropathy: role of Smad3.
American journal of physiology. Renal physiology, Volume: 298, Issue: 4
2010
[Influence of long-term use of low dose caulis Aristolochiae manshuriensis on partial nephrectomized rats].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, Volume: 22, Issue: 6
2002
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
Mutagenesis, Volume: 17, Issue: 4
2002
Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?
Kidney international, Volume: 59, Issue: 6
2001
Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants.
Journal of ethnopharmacology, Volume: 64, Issue: 2
1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (8)

ArticleYear
Effects of rhein and Rheum palmatum L. extract on the pharmacokinetics and tissue distribution of aristolochic acid I and its demethylated metabolite in rats.
Journal of ethnopharmacology, Mar-01, Volume: 267
2021
Comparative studies on the multi-component pharmacokinetics of Aristolochiae Fructus and honey-fried Aristolochiae Fructus extracts after oral administration in rats.
BMC complementary and alternative medicine, Feb-10, Volume: 17, Issue: 1
2017
[Study of pharmacokinetics of aristolochic acid I and II in rats].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 33, Issue: 19
2008
Fetal magnetic resonance imaging in isolated diaphragmatic hernia: volume of herniated liver and neonatal outcome.
American journal of obstetrics and gynecology, Volume: 200, Issue: 3
2009
Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.
Toxicon : official journal of the International Society on Toxinology, Volume: 50, Issue: 2
2007
[Pharmacodynamic and toxicologic comparative study of crude and processed radix aristolochice].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 32, Issue: 5
2007
[Advances in studies on pharmacokinetics of aristolochic acid I].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 31, Issue: 19
2006
[Studies on pharmacodynamic characteristics of aristolochic acid I in rats].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 29, Issue: 7
2004
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (3)

ArticleYear
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
MedChemComm, Feb-01, Volume: 8, Issue: 2
2017
Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy.
PloS one, Volume: 12, Issue: 8
2017
Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 38, Issue: 5
2010
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (49)

ArticleYear
Study on the difference and correlation between the contents and toxicity of aristolochic acid analogues in Aristolochia plants.
Journal of ethnopharmacology, Oct-28, Volume: 315
2023
Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.
Phytomedicine : international journal of phytotherapy and phytopharmacology, Volume: 114
2023
Anti-hyperglycemic potential and chemical constituents of Aristolochia triangularis Cham. leaves - A medicinal species native to Brazilian forests.
Journal of ethnopharmacology, Mar-01, Volume: 303
2023
Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.
Archives of toxicology, Volume: 95, Issue: 8
2021
Ethno medical knowledge and traditional use of Aristolochia bracteolata Lam. for malaria among local communities in Jubek State of South Sudan: A cross-sectional survey.
Journal of ethnopharmacology, Oct-28, Volume: 279
2021
Quantitation of Protein Adducts of Aristolochic Acid I by Liquid Chromatography-Tandem Mass Spectrometry: A Novel Method for Biomonitoring Aristolochic Acid Exposure.
Chemical research in toxicology, 01-18, Volume: 34, Issue: 1
2021
Benchmark dose analysis of multiple genotoxicity endpoints in gpt delta mice exposed to aristolochic acid I.
Mutagenesis, 04-28, Volume: 36, Issue: 1
2021
Defining in vivo dose-response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach.
Journal of applied toxicology : JAT, Volume: 40, Issue: 12
2020
Pig-a gene mutation assay study design: critical assessment of 3- versus 28-day repeat-dose treatment schedules.
Mutagenesis, 09-12, Volume: 35, Issue: 4
2020
Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.
PloS one, Volume: 14, Issue: 1
2019
Quantitation of DNA Adducts in Target and Nontarget Organs of Aristolochic Acid I-Exposed Rats: Correlating DNA Adduct Levels with Organotropic Activities.
Chemical research in toxicology, 03-18, Volume: 32, Issue: 3
2019
Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats.
Toxicological sciences : an official journal of the Society of Toxicology, 03-01, Volume: 156, Issue: 1
2017
Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 92
2016
Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening.
International journal of molecular sciences, Mar-16, Volume: 17, Issue: 3
2016
Comparison of DNA and RNA Adduct Formation: Significantly Higher Levels of RNA than DNA Modifications in the Internal Organs of Aristolochic Acid-Dosed Rats.
Chemical research in toxicology, Feb-16, Volume: 28, Issue: 2
2015
Analysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China.
Renal failure, Volume: 37, Issue: 2
2015
An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male rats.
Veterinary pathology, Volume: 51, Issue: 3
2014
Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice.
Biomedical chromatography : BMC, Volume: 27, Issue: 9
2013
Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats.
Environmental and molecular mutagenesis, Volume: 53, Issue: 5
2012
Developmental nephrotoxicity of aristolochic acid in a zebrafish model.
Toxicology and applied pharmacology, May-15, Volume: 261, Issue: 1
2012
Aristolochic acid nephropathy: variation in presentation and prognosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Volume: 27, Issue: 1
2012
Kinetics of aristolochic acid I after oral administration of Radix Aristolochiae or Guanxinsuhe preparation in canines.
Journal of ethnopharmacology, May-17, Volume: 135, Issue: 2
2011
A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Jan-15, Volume: 879, Issue: 2
2011
Proteomics investigation on aristolochic acid nephropathy: a case study on rat kidney tissues.
Analytical and bioanalytical chemistry, Volume: 399, Issue: 10
2011
Toxicological risks of Chinese herbs.
Planta medica, Volume: 76, Issue: 17
2010
Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells.
Oncology reports, Volume: 24, Issue: 1
2010
Liquid chromatography/mass spectrometry for investigating the biochemical effects induced by aristolochic acid in rats: the plasma metabolome.
Rapid communications in mass spectrometry : RCM, May-15, Volume: 24, Issue: 9
2010
Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
Journal of the National Cancer Institute, Feb-03, Volume: 102, Issue: 3
2010
Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.
Journal of the American Society of Nephrology : JASN, Volume: 21, Issue: 1
2010
Determination of aristolochic acid I in rat urine and plasma by high-performance liquid chromatography with fluorescence detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Apr-01, Volume: 877, Issue: 10
2009
Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry.
Mutation research, Nov-10, Volume: 646, Issue: 1-2
2008
TGF-beta1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI.
Journal of receptor and signal transduction research, Volume: 28, Issue: 4
2008
Liquid chromatography/mass spectrometry for metabonomics investigation of the biochemical effects induced by aristolochic acid in rats: the use of information-dependent acquisition for biomarker identification.
Rapid communications in mass spectrometry : RCM, Volume: 22, Issue: 6
2008
Aristolochic acid induced changes in the metabolic profile of rat urine.
Journal of pharmaceutical and biomedical analysis, Mar-13, Volume: 46, Issue: 4
2008
Aristolochic Acid induces heart failure in zebrafish embryos that is mediated by inflammation.
Toxicological sciences : an official journal of the Society of Toxicology, Volume: 100, Issue: 2
2007
[Nephrotoxicity of Aristolochia manshriensis and Longdan Xiegan decoction].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 32, Issue: 7
2007
[Advances in studies on pharmacokinetics of aristolochic acid I].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 31, Issue: 19
2006
[The nephrotoxicity in rats caused by Longdan Xiegan decoction].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 31, Issue: 10
2006
DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.
Mutation research, Dec-01, Volume: 602, Issue: 1-2
2006
NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 44, Issue: 7
2006
Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 44, Issue: 1
2006
Tumour induction in rats following exposure to short-term high dose aristolochic acid I.
Mutagenesis, Volume: 20, Issue: 1
2005
[Experimental study on oncogenicity of Aristolochia manshuriensis in rats].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, Volume: 21, Issue: 4
2001
Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Volume: 17, Issue: 3
2002
Long-term outcome of acute renal injury induced by Aristolochia manshuriensis Kom in rats.
Acta pharmacologica Sinica, Volume: 21, Issue: 12
2000
Cellular mechanisms by which oxytocin stimulates uterine PGF2 alpha synthesis in bovine endometrium: roles of phospholipases C and A2.
Domestic animal endocrinology, Volume: 14, Issue: 3
1997
[Double blind study of the influence of aristolochic acid on granulocyte phagocytic activity].
Arzneimittel-Forschung, Volume: 32, Issue: 4
1982
Effect of butylated hydroxyanisole on the level of DNA adduction by aristolochic acid in the rat forestomach and liver.
Japanese journal of cancer research : Gann, Volume: 81, Issue: 3
1990
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (1)

ArticleYear
Fatal renal failure due to the Chinese herb "GuanMu Tong" (Aristolochia manshuriensis): autopsy findings and review of literature.
Forensic science international, Jun-15, Volume: 199, Issue: 1-3
2010
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]